Bimekizumab Tops Secukinumab for Plaque Psoriasis
In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.